Since the RAS has been linked to hypertension and chronic kidney disease, there has been much interest in developing pharmacological inhibitors to attenuate or block its effects including angiotensin receptor blockers and angiotensin-converting enzyme inhibitors. The gene discussed is ACE; the disease is Hypertension.